Answers are grounded in this paper and cite their sources.
Dear Editor, T-follicular helper (Tfh) cells have been implicated in the pathogenesis of a variety of autoimmune disorders because of their central role in adaptive immune responses [1]. In particular, Tfh cells orchestrate germinal centre reactions by recruiting CXCR5-expressing B-lymphocytes via CXCL13 secretion, and control antigen-dependent maturation, isotype class-switching, and somatic hypermutation of naïve B-cells [1]. IgG4-related disease (IgG4-RD) is an emerging fibro-inflammatory condition characterized by relapsing–remitting tumour-like lesions and increased serum IgG4 concentration [2, 3]. B-lymphocytes play a central pathogenic role in IgG4-RD because active disease is associated with oligoclonal expansion of fibrogenic IgG4+ plasmablasts [4]. In addition, B-cell depletion therapy with rituximab typically leads to rapid clinical improvement and flares occur in parallel with re-emergence of clonally divergent plasmablasts [2–5]. Of note, these B-cell clones are marked by enhanced somatic hypermutation consistent with iterative rounds of...
No takes yet. Share an insight, caveat, or question.
Mancuso et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: